Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.47% |
| 2 | Technology | 8.38% |
| 3 | Healthcare | 7.46% |
| 4 | Consumer Discretionary | 5.14% |
| 5 | Industrials | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3376
NuScale Power
SMR
$3.81B
| $2.12M | ﹤0.01% |
312,085
+116,163
| +59% | +$942K |
|
|
NGD
3377
DELISTED
New Gold Inc
NGD
| $2.12M | ﹤0.01% |
1,957,461
+858,720
| +78% | +$1.06M |
|
3378
Bit Digital
BTBT
$516M
| $2.12M | ﹤0.01% |
+522,018
| New | +$1.35M |
|
3379
Spire
SR
$4.88B
| $2.11M | ﹤0.01% |
33,273
-181,930
| -85% | -$12.2M |
|
|
TVRD
3380
Tvardi Therapeutics
TVRD
$24.3M
| $2.11M | ﹤0.01% |
20,690
+20,343
| +5,863% | +$2.8M |
|
|
GAQ
3381
DELISTED
Generation Asia I Acquisition Limited Class A Ordinary Shares
GAQ
| $2.1M | ﹤0.01% |
200,000
| – | – |
|
3382
Lucid Motors
LCID
$1.97B
| $2.1M | ﹤0.01% |
30,528
+25,481
| +505% | +$1.82M |
|
3383
Transmedics
TMDX
$3.07B
| $2.1M | ﹤0.01% |
25,041
+15,124
| +153% | +$1.16M |
|
|
LCW
3384
DELISTED
Learn CW Investment Corporation Class A Ordinary Shares
LCW
| $2.1M | ﹤0.01% |
200,600
| – | – |
|
3385
CALL
CrowdStrike
CRWD
$224B
| $2.1M | ﹤0.01% |
57,200
-246,400
| -81% | -$8.58M |
|
3386
Rimini Street
RMNI
$527M
| $2.09M | ﹤0.01% |
436,553
+302,691
| +226% | +$1.25M |
|
3387
NeoGenomics
NEO
$2.32B
| $2.08M | ﹤0.01% |
129,679
+41,980
| +48% | +$692K |
|
3388
Innodata
INOD
$1.95B
| $2.08M | ﹤0.01% |
183,479
+50,215
| +38% | +$467K |
|
|
ZIMV
3389
DELISTED
ZimVie
ZIMV
| $2.07M | ﹤0.01% |
184,699
-1,163,689
| -86% | -$11.3M |
|
|
VLRS
3390
Controladora Vuela Compania de Aviacion
VLRS
$775M
| $2.07M | ﹤0.01% |
+148,609
| New | +$1.91M |
|
3391
Sturm, Ruger & Co
RGR
$595M
| $2.07M | ﹤0.01% |
39,078
+3,145
| +9% | +$172K |
|
3392
PUT
Opendoor
OPEN
$3.19B
| $2.07M | ﹤0.01% |
+531,960
| New | +$1.15M |
|
3393
Karyopharm Therapeutics
KPTI
$42.4M
| $2.06M | ﹤0.01% |
76,749
+75,831
| +8,260% | +$3.27M |
|
|
PETQ
3394
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $2.06M | ﹤0.01% |
135,774
-491,194
| -78% | -$6.3M |
|
3395
Primerica
PRI
$8.94B
| $2.06M | ﹤0.01% |
10,397
-25,628
| -71% | -$4.71M |
|
3396
CorMedix
CRMD
$647M
| $2.05M | ﹤0.01% |
517,999
+205,027
| +66% | +$1.01M |
|
3397
Cellebrite
CLBT
$3.01B
| $2.05M | ﹤0.01% |
284,826
+163,888
| +136% | +$956K |
|
3398
CALL
Ecopetrol
EC
$33.9B
| $2.05M | ﹤0.01% |
+200,000
| New | +$2.02M |
|
3399
PUT
NIO
NIO
$10.9B
| $2.05M | ﹤0.01% |
211,500
-688,500
| -77% | -$5.83M |
|
3400
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
$17.3B
| $2.05M | ﹤0.01% |
+30,722
| New | +$1.95M |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander's Q2 2023 filing shows 870 new, 2,213 increased, 2,337 reduced and 1,192 closed positions. Its largest new stake was ResMed: 632,015 shares worth $138M. The largest sale was Tesla, an estimated $491M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.